1. Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain;Arias;Virology,1993
2. Evidence that the envelope protein of flaviviruses encodes determinants of attenuation and virulence;Barrett,1990
3. Study of bivalent dengue vaccine in volunteers;Bhamarapravati;Lancet,1989
4. The clinical trial of trivalent dengue vaccine;Bhamarapravati;Southeast Asian J. Trop. Med. Public Health,1990
5. Immunization with a live attenuated dengue-2-virus candidate vaccine (16681-PDK 53): Clinical, immunological and biological responses in adult volunteers;Bhamarapravati;Bull. WHO,1987